The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Volume: 10, Issue: 1
Published: Jul 6, 2018
Abstract
There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer’s disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. In this report we describe the design of the study, the methods used and the characteristics of the participants. Participants were selected from...
Paper Details
Title
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Published Date
Jul 6, 2018
Volume
10
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.